1
|
Nicoliche T, Bartolomeo CS, Lemes RMR, Pereira GC, Nunes TA, Oliveira RB, Nicastro ALM, Soares ÉN, da Cunha Lima BF, Rodrigues BM, Maricato JT, Okuda LH, de Sairre MI, Prado CM, Ureshino RP, Stilhano RS. Antiviral, anti-inflammatory and antioxidant effects of curcumin and curcuminoids in SH-SY5Y cells infected by SARS-CoV-2. Sci Rep 2024; 14:10696. [PMID: 38730068 PMCID: PMC11087556 DOI: 10.1038/s41598-024-61662-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2023] [Accepted: 05/08/2024] [Indexed: 05/12/2024] Open
Abstract
COVID-19, caused by SARS-CoV-2, affects neuronal cells, causing several symptoms such as memory loss, anosmia and brain inflammation. Curcuminoids (Me08 e Me23) and curcumin (CUR) are derived from Curcuma Longa extract (EXT). Many therapeutic actions have been linked to these compounds, including antiviral action. Given the severe implications of COVID-19, especially within the central nervous system, our study aims to shed light on the therapeutic potential of curcuminoids against SARS-CoV-2 infection, particularly in neuronal cells. Here, we investigated the effects of CUR, EXT, Me08 and Me23 in human neuroblastoma SH-SY5Y. We observed that Me23 significantly decreased the expression of plasma membrane-associated transmembrane protease serine 2 (TMPRSS2) and TMPRSS11D, consequently mitigating the elevated ROS levels induced by SARS-CoV-2. Furthermore, Me23 exhibited antioxidative properties by increasing NRF2 gene expression and restoring NQO1 activity following SARS-CoV-2 infection. Both Me08 and Me23 effectively reduced SARS-CoV-2 replication in SH-SY5Y cells overexpressing ACE2 (SH-ACE2). Additionally, all of these compounds demonstrated the ability to decrease proinflammatory cytokines such as IL-6, TNF-α, and IL-17, while Me08 specifically reduced INF-γ levels. Our findings suggest that curcuminoid Me23 could serve as a potential agent for mitigating the impact of COVID-19, particularly within the context of central nervous system involvement.
Collapse
Affiliation(s)
- Tiago Nicoliche
- Department of Physiological Sciences, Santa Casa de São Paulo School of Medical Sciences (FCMSCSP), 61 Dr. Cesário Mota Junior Street, São Paulo, SP, 01221-020, Brazil
| | - Cynthia Silva Bartolomeo
- Department of Physiological Sciences, Santa Casa de São Paulo School of Medical Sciences (FCMSCSP), 61 Dr. Cesário Mota Junior Street, São Paulo, SP, 01221-020, Brazil
| | - Robertha Mariana Rodrigues Lemes
- Department of Biological Sciences, Federal University of São Paulo (UNIFESP), São Paulo, Brazil
- Post-Graduation Program in Chemistry-Biology, Federal University of São Paulo (UNIFESP), Diadema, Brazil
| | - Gabriela Cruz Pereira
- Department of Biochemistry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil
| | - Tamires Alves Nunes
- Department of Bioscience, Federal University of São Paulo (UNIFESP), São Paulo, Brazil
| | - Rafaela Brito Oliveira
- Department of Biological Sciences, Federal University of São Paulo (UNIFESP), São Paulo, Brazil
| | - Arthur Luiz Miranda Nicastro
- Department of Physiological Sciences, Santa Casa de São Paulo School of Medical Sciences (FCMSCSP), 61 Dr. Cesário Mota Junior Street, São Paulo, SP, 01221-020, Brazil
- Post-Graduation Program in Chemistry-Biology, Federal University of São Paulo (UNIFESP), Diadema, Brazil
| | | | | | - Beatriz Moreira Rodrigues
- Department of Microbiology, Immunology and Parasitology, Federal University of São Paulo (UNIFESP), São Paulo, Brazil
| | - Juliana Terzi Maricato
- Department of Microbiology, Immunology and Parasitology, Federal University of São Paulo (UNIFESP), São Paulo, Brazil
| | - Liria Hiromi Okuda
- Biological Institute, Agriculture and Supply Department, São Paulo, SP, Brazil
| | - Mirela Inês de Sairre
- Human and Natural Sciences Center, Federal University of ABC (UFABC), São Paulo, Brazil
| | - Carla Máximo Prado
- Department of Bioscience, Federal University of São Paulo (UNIFESP), São Paulo, Brazil
| | - Rodrigo Portes Ureshino
- Department of Biological Sciences, Federal University of São Paulo (UNIFESP), São Paulo, Brazil
- Post-Graduation Program in Chemistry-Biology, Federal University of São Paulo (UNIFESP), Diadema, Brazil
| | - Roberta Sessa Stilhano
- Department of Physiological Sciences, Santa Casa de São Paulo School of Medical Sciences (FCMSCSP), 61 Dr. Cesário Mota Junior Street, São Paulo, SP, 01221-020, Brazil.
- Post-Graduation Program in Chemistry-Biology, Federal University of São Paulo (UNIFESP), Diadema, Brazil.
| |
Collapse
|
2
|
Soares ÉN, Costa ACDS, Ferrolho GDJ, Ureshino RP, Getachew B, Costa SL, da Silva VDA, Tizabi Y. Nicotinic Acetylcholine Receptors in Glial Cells as Molecular Target for Parkinson's Disease. Cells 2024; 13:474. [PMID: 38534318 DOI: 10.3390/cells13060474] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2024] [Revised: 03/02/2024] [Accepted: 03/05/2024] [Indexed: 03/28/2024] Open
Abstract
Parkinson's disease (PD) is a progressive neurodegenerative disease characterized by resting tremor, bradykinesia, rigidity, and postural instability that also includes non-motor symptoms such as mood dysregulation. Dopamine (DA) is the primary neurotransmitter involved in this disease, but cholinergic imbalance has also been implicated. Current intervention in PD is focused on replenishing central DA, which provides remarkable temporary symptomatic relief but does not address neuronal loss and the progression of the disease. It has been well established that neuronal nicotinic cholinergic receptors (nAChRs) can regulate DA release and that nicotine itself may have neuroprotective effects. Recent studies identified nAChRs in nonneuronal cell types, including glial cells, where they may regulate inflammatory responses. Given the crucial role of neuroinflammation in dopaminergic degeneration and the involvement of microglia and astrocytes in this response, glial nAChRs may provide a novel therapeutic target in the prevention and/or treatment of PD. In this review, following a brief discussion of PD, we focus on the role of glial cells and, specifically, their nAChRs in PD pathology and/or treatment.
Collapse
Affiliation(s)
- Érica Novaes Soares
- Laboratory of Neurochemistry and Cell Biology, Department of Biochemistry and Biophysics, Institute of Health Sciences, Federal University of Bahia, Salvador 40110-902, BA, Brazil
| | - Ana Carla Dos Santos Costa
- Laboratory of Neurochemistry and Cell Biology, Department of Biochemistry and Biophysics, Institute of Health Sciences, Federal University of Bahia, Salvador 40110-902, BA, Brazil
| | - Gabriel de Jesus Ferrolho
- Laboratory of Neurochemistry and Cell Biology, Department of Biochemistry and Biophysics, Institute of Health Sciences, Federal University of Bahia, Salvador 40110-902, BA, Brazil
- Laboratory of Neurosciences, Institute of Health Sciences, Federal University of Bahia, Salvador 40110-902, BA, Brazil
| | - Rodrigo Portes Ureshino
- Department of Biological Sciences, Universidade Federal de São Paulo, Diadema 09961-400, SP, Brazil
- Laboratory of Molecular and Translational Endocrinology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo 04039-032, SP, Brazil
| | - Bruk Getachew
- Department of Pharmacology, College of Medicine, Howard University, 520 W Street NW, Washington, DC 20059, USA
| | - Silvia Lima Costa
- Laboratory of Neurochemistry and Cell Biology, Department of Biochemistry and Biophysics, Institute of Health Sciences, Federal University of Bahia, Salvador 40110-902, BA, Brazil
| | - Victor Diogenes Amaral da Silva
- Laboratory of Neurochemistry and Cell Biology, Department of Biochemistry and Biophysics, Institute of Health Sciences, Federal University of Bahia, Salvador 40110-902, BA, Brazil
- Laboratory of Neurosciences, Institute of Health Sciences, Federal University of Bahia, Salvador 40110-902, BA, Brazil
| | - Yousef Tizabi
- Department of Pharmacology, College of Medicine, Howard University, 520 W Street NW, Washington, DC 20059, USA
| |
Collapse
|
3
|
Lima IS, Soares ÉN, Nonaka CKV, Souza BSDF, dos Santos BL, Costa SL. Flavonoid Rutin Presented Anti-Glioblastoma Activity Related to the Modulation of Onco miRNA-125b Expression and STAT3 Signaling and Impact on Microglia Inflammatory Profile. Brain Sci 2024; 14:90. [PMID: 38248305 PMCID: PMC10814059 DOI: 10.3390/brainsci14010090] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2023] [Revised: 01/09/2024] [Accepted: 01/13/2024] [Indexed: 01/23/2024] Open
Abstract
Glioblastoma (GBM) is the most aggressive and treatment-resistant brain tumor. In the GBM microenvironment, interaction with microglia is associated with the dysregulation of cytokines, chemokines, and miRNAs, contributing to angiogenesis, proliferation, anti-apoptosis, and chemoresistance. The flavonoid rutin can inhibit glioma cell growth associated with microglial activation and production of pro-inflammatory mediators by mechanisms that are still poorly understood. The present study investigated the effect of rutin on viability, regulation of miRNA-125b, and the STAT3 expression in GBM cells, as well as the effects on the modulation of the inflammatory profile and STAT3 expression in microglia during indirect interaction with GBM cells. Human GL15-GBM cells and human C20 microglia were treated or not with rutin for 24 h. Rutin (30-50 μM) significantly reduced the viability of GL15 cells; however, it did not affect the viability of microglia. Rutin (30 μM) significantly reduced the expression of miRNA-125b in the cells and secretome and STAT3 expression. Microglia submitted to the conditioned medium from GBM cells treated with rutin showed reactive morphology associated with reduced expression of IL-6, TNF, and STAT3. These results reiterate the anti-glioma effects of the flavonoid, which may also modulate microglia towards a more responsive anti-tumor phenotype, constituting a promising molecule for adjuvant therapy to GBM.
Collapse
Affiliation(s)
- Irlã Santos Lima
- Laboratory of Neurochemistry and Cellular Biology, Institute of Health Sciences, Federal University of Bahia, Salvador 40231-300, Brazil; (I.S.L.); (É.N.S.)
| | - Érica Novaes Soares
- Laboratory of Neurochemistry and Cellular Biology, Institute of Health Sciences, Federal University of Bahia, Salvador 40231-300, Brazil; (I.S.L.); (É.N.S.)
| | - Carolina Kymie Vasques Nonaka
- Center of Biotechnology and Cell Therapy, São Rafael Hospital, D’Or Institute for Research and Teaching (IDOR), Salvador 41253-190, Brazil; (C.K.V.N.); (B.S.d.F.S.)
| | - Bruno Solano de Freitas Souza
- Center of Biotechnology and Cell Therapy, São Rafael Hospital, D’Or Institute for Research and Teaching (IDOR), Salvador 41253-190, Brazil; (C.K.V.N.); (B.S.d.F.S.)
| | - Balbino Lino dos Santos
- Laboratory of Neurochemistry and Cellular Biology, Institute of Health Sciences, Federal University of Bahia, Salvador 40231-300, Brazil; (I.S.L.); (É.N.S.)
- College of Nursing, Federal University of Vale do São Francisco, Petrolina 56304-917, Brazil
| | - Silvia Lima Costa
- Laboratory of Neurochemistry and Cellular Biology, Institute of Health Sciences, Federal University of Bahia, Salvador 40231-300, Brazil; (I.S.L.); (É.N.S.)
- National Institute of Translation Neuroscience (INNT), Rio de Janeiro 21941-902, Brazil
| |
Collapse
|
4
|
da Silva SVS, Barboza OM, Souza JT, Soares ÉN, dos Santos CC, Pacheco LV, Santos IP, Magalhães TBDS, Soares MBP, Guimarães ET, Meira CS, Costa SL, da Silva VDA, de Santana LLB, de Freitas Santos Júnior A. Structural Design, Synthesis and Antioxidant, Antileishmania, Anti-Inflammatory and Anticancer Activities of a Novel Quercetin Acetylated Derivative. Molecules 2021; 26:molecules26226923. [PMID: 34834016 PMCID: PMC8623808 DOI: 10.3390/molecules26226923] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2021] [Revised: 11/12/2021] [Accepted: 11/14/2021] [Indexed: 02/01/2023] Open
Abstract
Quercetin (Q) is a bioflavonoid with biological potential; however, poor solubility in water, extensive enzymatic metabolism and a reduced bioavailability limit its biopharmacological use. The aim of this study was to perform structural modification in Q by acetylation, thus, obtaining the quercetin pentaacetate (Q5) analogue, in order to investigate the biological potentials (antioxidant, antileishmania, anti-inflammatory and cytotoxicity activities) in cell cultures. Q5 was characterized by FTIR, 1H and 13C NMR spectra. The antioxidant potential was evaluated against the radical ABTS•+. The anti-inflammatory potential was evaluated by measuring the pro-inflammatory cytokine tumor necrosis factor (TNF) and the production of nitric oxide (NO) in peritoneal macrophages from BALB/c mice. Cytotoxicity tests were performed using the AlamarBlue method in cancer cells HepG2 (human hepatocarcinoma), HL-60 (promyelocytic leukemia) and MCR-5 (healthy human lung fibroblasts) as well as the MTT method for C6 cell cultures (rat glioma). Q and Q5 showed antioxidant activity of 29% and 18%, respectively, which is justified by the replacement of hydroxyls by acetyl groups. Q and Q5 showed concentration-dependent reductions in NO and TNF production (p < 0.05); Q and Q5 showed higher activity at concentrations > 40µM when compared to dexamethasone (20 µM). For the HL-60 lineage, Q5 demonstrated selectivity, inducing death in cancer cells, when compared to the healthy cell line MRC-5 (IC50 > 80 µM). Finally, the cytotoxic superiority of Q5 was verified (IC50 = 11 µM), which, at 50 µM for 24 h, induced changes in the morphology of C6 glioma cells characterized by a round body shape (not yet reported in the literature). The analogue Q5 had potential biological effects and may be promising for further investigations against other cell cultures, particularly neural ones.
Collapse
Affiliation(s)
- Saul Vislei Simões da Silva
- Department of Life Sciences, State University of Bahia (UNEB), Salvador 41150-000, BA, Brazil; (S.V.S.d.S.); (O.M.B.); (L.V.P.); (T.B.d.S.M.); (E.T.G.); (C.S.M.); (L.L.B.d.S.)
| | - Orlando Maia Barboza
- Department of Life Sciences, State University of Bahia (UNEB), Salvador 41150-000, BA, Brazil; (S.V.S.d.S.); (O.M.B.); (L.V.P.); (T.B.d.S.M.); (E.T.G.); (C.S.M.); (L.L.B.d.S.)
| | - Jéssica Teles Souza
- Laboratory of Neurochemistry and Cell Biology, Department of Biochemistry and Biophysics, Federal University of Bahia, Salvador 40231-300, BA, Brazil; (J.T.S.); (É.N.S.); (C.C.d.S.); (S.L.C.); (V.D.A.d.S.)
| | - Érica Novaes Soares
- Laboratory of Neurochemistry and Cell Biology, Department of Biochemistry and Biophysics, Federal University of Bahia, Salvador 40231-300, BA, Brazil; (J.T.S.); (É.N.S.); (C.C.d.S.); (S.L.C.); (V.D.A.d.S.)
| | - Cleonice Creusa dos Santos
- Laboratory of Neurochemistry and Cell Biology, Department of Biochemistry and Biophysics, Federal University of Bahia, Salvador 40231-300, BA, Brazil; (J.T.S.); (É.N.S.); (C.C.d.S.); (S.L.C.); (V.D.A.d.S.)
| | - Luciano Vasconcellos Pacheco
- Department of Life Sciences, State University of Bahia (UNEB), Salvador 41150-000, BA, Brazil; (S.V.S.d.S.); (O.M.B.); (L.V.P.); (T.B.d.S.M.); (E.T.G.); (C.S.M.); (L.L.B.d.S.)
- Gonçalo Moniz Institute, FIOCRUZ, Salvador 40296-710, BA, Brazil; (I.P.S.); (M.B.P.S.)
| | | | - Tatiana Barbosa dos Santos Magalhães
- Department of Life Sciences, State University of Bahia (UNEB), Salvador 41150-000, BA, Brazil; (S.V.S.d.S.); (O.M.B.); (L.V.P.); (T.B.d.S.M.); (E.T.G.); (C.S.M.); (L.L.B.d.S.)
| | - Milena Botelho Pereira Soares
- Gonçalo Moniz Institute, FIOCRUZ, Salvador 40296-710, BA, Brazil; (I.P.S.); (M.B.P.S.)
- SENAI Institute of Innovation in Health Advanced Systems (CIMATEC ISI SAS), University Center SENAI/CIMATEC, Salvador 41650-010, BA, Brazil
| | - Elisalva Teixeira Guimarães
- Department of Life Sciences, State University of Bahia (UNEB), Salvador 41150-000, BA, Brazil; (S.V.S.d.S.); (O.M.B.); (L.V.P.); (T.B.d.S.M.); (E.T.G.); (C.S.M.); (L.L.B.d.S.)
- Gonçalo Moniz Institute, FIOCRUZ, Salvador 40296-710, BA, Brazil; (I.P.S.); (M.B.P.S.)
| | - Cássio Santana Meira
- Department of Life Sciences, State University of Bahia (UNEB), Salvador 41150-000, BA, Brazil; (S.V.S.d.S.); (O.M.B.); (L.V.P.); (T.B.d.S.M.); (E.T.G.); (C.S.M.); (L.L.B.d.S.)
- Gonçalo Moniz Institute, FIOCRUZ, Salvador 40296-710, BA, Brazil; (I.P.S.); (M.B.P.S.)
- SENAI Institute of Innovation in Health Advanced Systems (CIMATEC ISI SAS), University Center SENAI/CIMATEC, Salvador 41650-010, BA, Brazil
| | - Silvia Lima Costa
- Laboratory of Neurochemistry and Cell Biology, Department of Biochemistry and Biophysics, Federal University of Bahia, Salvador 40231-300, BA, Brazil; (J.T.S.); (É.N.S.); (C.C.d.S.); (S.L.C.); (V.D.A.d.S.)
| | - Victor Diógenes Amaral da Silva
- Laboratory of Neurochemistry and Cell Biology, Department of Biochemistry and Biophysics, Federal University of Bahia, Salvador 40231-300, BA, Brazil; (J.T.S.); (É.N.S.); (C.C.d.S.); (S.L.C.); (V.D.A.d.S.)
| | - Lourenço Luís Botelho de Santana
- Department of Life Sciences, State University of Bahia (UNEB), Salvador 41150-000, BA, Brazil; (S.V.S.d.S.); (O.M.B.); (L.V.P.); (T.B.d.S.M.); (E.T.G.); (C.S.M.); (L.L.B.d.S.)
| | - Aníbal de Freitas Santos Júnior
- Department of Life Sciences, State University of Bahia (UNEB), Salvador 41150-000, BA, Brazil; (S.V.S.d.S.); (O.M.B.); (L.V.P.); (T.B.d.S.M.); (E.T.G.); (C.S.M.); (L.L.B.d.S.)
- Correspondence: or ; Tel.: +55-71-3117-5313
| |
Collapse
|